One of the important aspects of the pathogenesis of neuroendocrine tumors (NET), which are built with well or moderate differentiated tumor cells of NEN, is the interaction between ligands, such as somatostatin and its analogues, and somatostatin receptors. This evidence concerns the gene SST and neoplasm.